Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway.
- Published in:
- Nature Communications, 2016, v. 7, n. 5, p. 11445, doi. 10.1038/ncomms11445
- By:
- Publication type:
- Article
Works matching AU Duarte-Neves, Joana
Results: 4
1
2
Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 19, p. 5451, doi. 10.1093/hmg/ddv271
- By:
- Publication type:
- Article
3
Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82339-5
- By:
- Publication type:
- Article
4
Identification of the calpain‐generated toxic fragment of ataxin‐3 protein provides new avenues for therapy of Machado–Joseph disease| Spinocerebellar ataxia type 3.
- Published in:
- Neuropathology & Applied Neurobiology, 2022, v. 48, n. 1, p. 1, doi. 10.1111/nan.12748
- By:
- Publication type:
- Article